Giant Biogene Holding Co., Ltd. (2367.HK)

HKD 78.05

(0.13%)

Annual Income Statements

(In CNY)
Breakdown 2023 2022 2021 2020 2019
Revenue 3.52 Billion 2.36 Billion 1.55 Billion 1.19 Billion 956.7 Million
Cost of Revenue 577 Million 369.2 Million 198.14 Million 183.4 Million 159.99 Million
Gross Profit 2.94 Billion 1.99 Billion 1.35 Billion 1 Billion 796.71 Million
Operating Expenses 1.28 Billion 817.31 Million 425.62 Million 198 Million 119.04 Million
Selling, General and Administrative Expenses 1.26 Billion 817.44 Million 353.14 Million 162.3 Million 98.09 Million
Research and Development Expenses 74.96 Million 44.04 Million 24.95 Million 13.38 Million 11.4 Million
Other Expenses - -44.16 Million 47.52 Million 22.31 Million 9.55 Million
Cost and Expenses 1.85 Billion 1.18 Billion 623.77 Million 381.41 Million 279.03 Million
Operating Income 1.61 Billion 1.18 Billion 914.56 Million 651.8 Million 688.64 Million
Interest Expense 112 Thousand 21 Thousand - - -
Income Tax Expense 296.88 Million 176.16 Million 144.78 Million 146.75 Million 101.81 Million
Earnings before Tax 1.74 Billion 1.17 Billion 972.91 Million 973.24 Million 676.99 Million
Net Income 1.45 Billion 1 Billion 828.13 Million 826.45 Million 552.26 Million
Earnings Per Share Basic 1.48 0.99 0.84 0.83 0.56
Earnings Per Share Diluted 1.48 0.98 0.84 0.83 0.56
Weighted Average Shares Outstanding 980.91 Million 976 Million 974.79 Million 991.6 Million 991.6 Million
Weighted Average Shares Outstanding (Diluted) 982.71 Million 1.02 Billion 991.6 Million 991.6 Million 991.6 Million
Gross Margin 0.84 0.84 0.87 0.85 0.83
EBIT Margin 0.50 0.51 0.60 0.57 0.74
Profit Margin 0.41 0.42 0.53 0.69 0.58
EBITDA 1.77 Billion 1.2 Billion 938.77 Million 674.1 Million 706.52 Million
Earnings Before Tax Margin 0.46 0.50 0.59 0.55 0.72

Income Statement Charts